Senior VP, Research & Development
Dave previously served in the positions of Research Fellow and Chief Scientific Officer at Dermira, Inc. Prior to its acquisition by Dermira in 2011, Dave was a co-founder and VP Research of Valocor Therapeutics. Previously, he headed preclinical dermatology research at QLT, Inc. employing high-throughput screening, molecular biology, cell signaling-profiling and gene expression methodologies combined with disease-relevant in vivo test systems to identify and characterize the activities of novel small-molecule drug candidates. He has extensive industrial research experience in cellular immunology, inflammation and autoimmunity with an extensive scientific publication record in these areas. Dave received his PhD from the University of British Columbia (Immunology & Microbiology).
Clinical Pharmacy Pharmaceutical Administration Medicinal Chemistry